The design and synthesis of novel orally active inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. SAR of in vitro and in vivo studies.

Source:http://linkedlifedata.com/resource/pubmed/id/14592511

Bioorg. Med. Chem. Lett. 2003 Nov 17 13 22 4077-80

Download in:

View as

General Info

PMID
14592511